Citigroup Inc Legend Biotech Corp Call Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	BUY	$63.16 - $76.5 $1.57 Million - $1.9 Million	24,900 New	24,900 $1.67 Million
Q1 2023 May 11, 2023	BUY	$43.42 - $57.37 $1.29 Million - $1.71 Million	29,800 New	29,800 $1.44 Million
Q3 2022 Nov 10, 2022	BUY	$38.15 - $57.1 $534,100 - $799,400	14,000 Added 88.61%	29,800 $1.22 Million
Q2 2022 Aug 10, 2022	SELL	$33.54 - $55.0 $140,868 - $231,000	-4,200 Reduced 21.0%	15,800 $869,000
Q1 2022 May 12, 2022	BUY	$31.02 - $48.18 $620,400 - $963,600	20,000 New	20,000 $727,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.25B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.